Sort
130,381 grants matching “hiv”
Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders
$2,734,318Mitchell J Weiss · St. Jude Children'S Research Hospital · P01 · FY2020 · HL
Investigations of Methylmalonic Acidemia and Related Disorders
$2,733,586Charles P Venditti · National Human Genome Research Institute · ZIA · FY2024 · HG
Centers for AIDS Research (CFAR)
$2,733,379Kent J. Weinhold · Duke University · P30 · FY2017 · AI
Scale It Up Management Core
$2,733,377Bonita Francess Stanton · Florida State University · U19 · FY2020 · HD
Soweto Clinical Trials Unit
$2,732,845Glenda Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2012 · AI
TARGET: INCREASING ACCESS TO HIV COUNSELING, TESTING & ENHANCING HIV/AIDS PREVENT
$2,732,500Dennis Walto · Population Services International · U2G · FY2013 · GH
Adjuvant Discovery for Vaccines against Influenza Virus
$2,730,922Ofer Levy · Boston Children'S Hospital · N01 · FY2018 · AI
FOGARTY AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAM
$2,730,731Johns Hopkins University · D43 · FY2002 · TW
HIV PREVENTION TRIALS UNIT
$2,730,098Harvard University (Sch Of Public Hlth) · U01 · FY2003 · AI
The University of North Carolina Center for AIDS Research
$2,729,963Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2016 · AI
The University of North Carolina Center for AIDS Research
$2,729,963Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2017 · AI
Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders
$2,728,503Mitchell J Weiss · St. Jude Children'S Research Hospital · P01 · FY2021 · HL
Washington Metropolitan Women's Interagency HIV Study
$2,727,492Mary A Young · Georgetown University · U01 · FY2008 · AI
Phage/Salmonella interactions during oxidative stress
$2,727,148Andres Vazquez-Torres · University Of Colorado Denver · R01 · FY2025 · AI
NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS
$2,726,389Sampa Santra · Beth Israel Deaconess Medical Center · N01 · FY2014 · AI
Development of Novel Immunogens for Vaccines to HIV-1
$2,725,643Robert Gerald Whalen · Maxygen, Inc. · P01 · FY2008 · AI
ADVANCING MULTI COUNTRY HIV SUPPORT IN COLLABORATION WITH DHAPP AND PARTNER MILITARIES FOR SUSTAINABLE HIV EPIDEMIC CONTROL (MULTI COUNTRY)
$2,725,432Population Services International · · FY2022 · Defense Health Agency
Genetic Analysis of Resistance to Viral Infection
$2,725,363Bruce A Beutler · Ut Southwestern Medical Center · P01 · FY2012 · AI
SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS
$2,725,226Barbara Driver · Westat, Inc. · N01 · FY2023 · HD
Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders
$2,722,946Mitchell J Weiss · St. Jude Children'S Research Hospital · P01 · FY2022 · HL
EXPANDED & INTEGRATED HUMAN IMMUNODEFICIENCY VIRUS (HIV) TESTING FOR POPULATIONS
$2,721,112Claudia E. Gray · Maryland State Department Of Health · U62 · FY2008 · PS
Center for AIDS Research
$2,720,842Douglas D Richman · University Of California, San Diego · P30 · FY2008 · AI
China's Integrated Programs for Research on AIDS
$2,720,681Yiming Shao · National Center For Aids/Std Control And Prevention · U19 · FY2006 · AI
Vanderbilt HIV Clinical Trials Unit (CTU)
$2,720,209David W Haas · Vanderbilt University Medical Center · UM1 · FY2025 · AI
UNC MACS/WIHS Combined Cohort Study Clinical Research Site
$2,720,100Michelle Floris-Moore · Univ Of North Carolina Chapel Hill · U01 · FY2023 · HL